Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
6.06
+0.23 (3.95%)
At close: Nov 6, 2024, 4:00 PM
6.14
+0.08 (1.32%)
After-hours: Nov 6, 2024, 4:36 PM EST
Lipocine Employees
Lipocine had 17 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
17
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$282,408
Profits / Employee
-$499,308
Market Cap
32.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Concord Medical Services Holdings | 727 |
FibroGen | 486 |
Neuronetics | 203 |
AN2 Therapeutics | 41 |
Elevation Oncology | 29 |
Daré Bioscience | 26 |
vTv Therapeutics | 16 |
Reviva Pharmaceuticals Holdings | 15 |
LPCN News
- 1 hour ago - Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024 - PRNewsWire
- 7 days ago - Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea - PRNewsWire
- 4 weeks ago - Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results - PRNewsWire
- 4 weeks ago - Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries - PRNewsWire
- 5 weeks ago - Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024 - PRNewsWire
- 5 weeks ago - Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference - PRNewsWire
- 2 months ago - Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek® - PRNewsWire
- 2 months ago - Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire